Literature DB >> 10785253

Cores in hypothyroid myopathy: a clinical, histological and immunofluorescence study.

G Modi1.   

Abstract

Fifteen patients with primary hypothyroidism were evaluated neurologically. Needle biopsies of skeletal muscle were obtained using a Bergstrom needle. In 73% of the patients, cores were identified histologically and by electron microscopy in the skeletal muscle of these patients. The presence of cores correlated with the severity of hypothyroidism, muscle hypertrophy, cramps and the duration of the hypothyroid state. There was no significant correlation with muscle weakness. Immunofluorescence studies with N-CAM antibodies demonstrated staining of the sarcolemma, cytoplasm and central regions (cores) in the hypothyroid muscle. These imply that the presence of cores in hypothyroid myopathy is due to reactivation of embryonic proteins that disrupt skeletal muscle architecture.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10785253     DOI: 10.1016/s0022-510x(00)00266-5

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

Review 1.  Hypothyroid myopathy: A peculiar clinical presentation of thyroid failure. Review of the literature.

Authors:  Alessandro Sindoni; Carmelo Rodolico; Maria Angela Pappalardo; Simona Portaro; Salvatore Benvenga
Journal:  Rev Endocr Metab Disord       Date:  2016-12       Impact factor: 6.514

Review 2.  Polymyositis with mitochondrial pathology or atypical form of sporadic inclusion body myositis: case series and review of the literature.

Authors:  George K Papadimas; Charalampos Kokkinis; Sophia Xirou; Margarita Chrysanthou; Evangelia Kararizou; Constantinos Papadopoulos
Journal:  Rheumatol Int       Date:  2019-05-04       Impact factor: 2.631

3.  Chronic myopathy due to immunoglobulin light chain amyloidosis.

Authors:  Irini Manoli; Justin Y Kwan; Qian Wang; Elisabeth J Rushing; Maria Tsokos; Andrew E Arai; Warner M Burch; Angela Dispenzieri; Alexandra C McPherron; William A Gahl
Journal:  Mol Genet Metab       Date:  2013-02-04       Impact factor: 4.797

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.